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Abstract
Background: Breast cancer and its treatment-related adverse effects are harmful to physical, psychological, and
social functioning, leading to health-related quality of life (HRQoL) impairment in patients. Many programs have
been used with this population for HRQoL improvement; however, few studies have considered the physical,
psychological, and social health domains comprehensively, and few have constructed multimodal standard nursing
interventions based on specific theories. The purpose of this trial is to examine the effect of a health belief model
(HBM)-based multimodal standard nursing program (MSNP) on HRQoL in female patients with breast cancer.
Methods: This is a two-arm single-blind cluster randomized controlled trial (cRCT) in clinical settings. Twelve tertiary
hospitals will be randomly selected from the 24 tertiary hospitals in Xi’an, China, and allocated to the intervention
arm and control arm using a computer-generated random numbers table. Inpatient female patients with breast
cancer from each hospital will receive either MSNP plus routine nursing care immediately after recruitment
(intervention arm), or only routine nursing care (control arm). The intervention will be conducted by trained nurses
for 12 months. All recruited female patients with breast cancer, participating clinical staff, and trained data collectors
from the 12 hospitals will be blind with respect to group allocation. Patients of the control arm will not be offered
any information about the MSNP during the study period to prevent bias. The primary outcome is HRQoL
measured through the Functional Assessment of Cancer Therapy-Breast version 4.0 at 12 months. Secondary
outcomes include pain, fatigue, sleep, breast cancer-related lymphedema, and upper limb function, which are
evaluated by a visual analogue scale, the circumference method, and the Constant-Murley Score.
Discussion: This trial will provide important evidence on the effectiveness of multimodal nursing interventions
delivered by nurses in clinical settings. Study findings will inform strategies for scaling up comprehensive standard
intervention programs on health management in the population of female patients with breast cancer.
Trial registration: Chictr.org.cn ChiCTR-IOR-16008253 (April 9, 2016)
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Background
Breast cancer is the most common malignant tumor in
the female population. Global statistics in 2012 indicated
that about 1.7 million new cases were diagnosed and
522,000 died from the disease [1, 2]. In China, as in
most other countries, breast cancer is prevalent in
women. According to a report in 2014, Chinese cases
accounted for 12.2 % of all newly diagnosed breast can-
cer cases and 9.6 % of all deaths from breast cancer
worldwide [3]. Over the course of illness and treatment,
breast cancer patients experience many acute and
chronic adverse effects. They also face unique challenges
to health and well-being as a result of their cancer, its
treatment, and comorbidities [4–7].
Health-related quality of life (HRQoL) is broadly con-
ceptualized as individuals’ perceptions of their physical
health, psychological health, social relationships, rela-
tionship to their environment, independence level, and
personal beliefs [8]. With changing medical models,
HRQoL has been regarded as a key index for evaluating
global therapeutic effects and survival status in popula-
tions of patients with cancer [9]. Given negative influences
of the illness and treatment, breast cancer patients experi-
ence pain, fatigue, negative psychological states, self-image
alteration, body function limitations, self-esteem reduc-
tion, and risk of recurrence, which severely impact phys-
ical, psychological, and social functioning [10–17]. Breast
cancer patients also have been shown to have poorer
HRQoL in comparison with the general population, espe-
cially among patients under 50 years of age [18, 19].
To improve HRQoL for breast cancer patients, many
programs have been used with this population, such as
art therapy (e.g., music therapy, dance/movement ther-
apy) [20–22], exercise interventions (e.g., physical exer-
cise/activity, resistance exercise, aerobic exercise, yoga)
[23–28], psychoeducational support (e.g., health education,
psychosocial support, spiritual group therapy) [29–33],
and multimodal programs (e.g., rehabilitation programs,
physiotherapy programs, exercise programs) [34–37], with
different effects on HRQoL. However, existing or po-
tential health problems in physical, psychological, and
social domains have not been considered comprehen-
sively. Additionally, the previously mentioned programs
fail to describe intervention parameters such as time,
frequency, or strength in an explicit manner, leading to
their unsuitability as standard nursing interventions.
Moreover, few studies have constructed a multimodal
standard nursing program (MSNP) for breast cancer
patient populations [38].
Theoretical framework
The MSNP is developed based on the Health Belief
Model (HBM), which attempts to explain and predict
health behaviors by focusing on the attitudes and beliefs
of individuals. The HBM comprises four constructs: per-
ceived susceptibility, perceived severity, perceived bene-
fits, and perceived barriers. These concepts are proposed
to account for people’s readiness to act [39]. Cues to
action are thought to activate readiness and stimulate
overt behavior. Self-efficacy or confidence promotes the
performance of an action. Moreover, a person will take
a health-related action if it is felt that a negative health
condition can be avoided, there is a positive expect-
ation about taking a recommended action, and a belief
exists that a recommended health action can be taken
successfully [40].
The HBM has been widely used in different popula-
tions [41–45]. However, it has rarely been employed as
a theoretical guide in developing nursing intervention
strategies in patients with breast cancer [46–48]. Based
on the HBM, influencing factors can be explored from
physical, psychological, and social viewpoints. There-
fore, perceived susceptibility (e.g., risk of deterioration
or recurrence), perceived severity (e.g., complications
due to delayed treatment), perceived benefits (e.g.,
positive feedback following MSNP implementation),
and perceived barriers (e.g., impediments to MSNP
implementation) can be identified during the treat-
ment and nursing process to aid in the development of
the MSNP (Fig. 1).
Aims and objectives
The aim of this trial is to evaluate the effectiveness of a
MSNP for female patients with breast cancer in Xi’an,
China. The primary objective is to test for effects of the
MSNP on HRQoL enhancement. The secondary objec-
tives are to assess improvements in pain, fatigue, sleep,
breast cancer-related lymphedema (BCRL), and upper
limb function.
Based on these objectives, the primary hypothesis is
that breast cancer patients receiving MSNP will achieve
better HRQoL than a control arm at 12 months. The
secondary hypotheses are that patients receiving the
intervention will have (i) improved HRQoL at 1, 3, and
6 months; (ii) lower pain scores and less BCRL occur-
rence; and (iii) improved fatigue, sleep, and upper limb
function at 1, 3, 6, and 12 months.
Methods
Design
This is a two-arm single-blind cluster randomized con-
trolled trial (cRCT) in clinical settings with female breast
cancer patients.
Participants
Participants are inpatients with breast cancer. Inclusion
criteria are newly diagnosed with breast cancer, female,
aged 18 years and older, preparing to receive radical
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mastectomy and other auxiliary treatments (e.g., chemo-
therapy, radiotherapy, endocrine therapy), and providing
written informed consent. Patients with cognitive disor-
ders, psychiatric disorders, other malignant tumors, ac-
tive infection, or other severe potential infection will be
excluded. Cognitive disorders and psychiatric disorders
will be screened using DSM-V (Diagnostic and Statistical
Manual of Mental Disorders, 5th ed.) criteria [49]. Rea-
sons for refusal to participate will be documented.
Sample size and randomization
The sample size was calculated based on the FACT-
Bv4.0 total score of similar intervention studies (two-
arm trials with Chinese mainland female patients with
breast cancer employing a 12-month follow-up period).
According to an eligible study [50], 74 patients (37 in
each arm) will be needed to detect a between-arm
change of 6.74 in the FACT-Bv4.0 total score with a
power of 80 % at a 5 % level of statistical significance.
The sample size was increased to 90 patients (45 in each
arm) to allow for a 20 % dropout rate. Assuming an
intra-cluster correlation coefficient (ICC) of about 0.1
and 30 patients per cluster, the sample size adjusting
for clustering is 12 clusters or 360 patients [51]. That
is, a total of 12 tertiary hospitals will be required in the
trial, with 6 hospitals in each arm and 30 patients per
hospital on average.
The 12 tertiary hospitals will be randomly selected
from the 24 tertiary hospitals in Xi’an district and allo-
cated to the intervention and control arms using a
computer-generated random numbers table. Selection
and allocation of the 12 hospitals will be carried out in-
dependently by a member of the research team.
Procedure
Following random selection and allocation of the 12
tertiary hospitals, eligible female inpatients with breast
cancer from each hospital will receive either MSNP
plus routine nursing care immediately after recruit-
ment (intervention arm), or only routine nursing care
(control arm). The patients in both arms will provide
demographic data and complete the pre-test of the
FACT-Bv4.0, VAS, arm circumference, and CMS prior
to the intervention. After the baseline measurement,
four post-tests (i.e., FACT-Bv4.0, VAS, arm circumfer-
ence, and CMS) at 1, 3, 6, and 12 months will be con-
ducted. Items on the questionnaire will be asked of all
patients and their answers will be recorded by trained
data collectors. The flow chart of the cRCT procedure
is depicted in Fig. 2.
Outcomes and measurements
The primary outcome is HRQoL measured by the Func-
tional Assessment of Cancer Therapy-Breast version 4.0
(FACT-Bv4.0) at 12 months.
FACT-Bv4.0
The 36-item Chinese (simple) FACT-Bv4.0 consists of
a general cancer subscale (FACT-G) and a breast-
cancer-specific subscale for additional concerns (BCS).
The FACT-G comprises physical well-being (PWB,
seven items), social/family well-being (SFWB, seven
items), emotional well-being (EWB, six items), and
functional well-being (FWB, seven items). The BCS
comprises nine items, each rated on a 5-point Likert
scale (from 0 to 4). The FACT-Bv4.0 total score, which
is the sum of scores of the FACT-G and BCS ranges
Fig. 1 Conceptual framework for the multimodal standard nursing program (MSNP) development
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from 0 to 144. A higher score indicates better HRQoL
of the patient [52]. The reliability, validity, and respon-
siveness of the Chinese (simple) FACT-Bv4.0 has been
confirmed in Chinese patients with breast cancer [53].
The secondary outcomes include pain, fatigue, sleep,
BCRL, and upper limb function evaluated by a visual
analogue scale (VAS), the circumference method, and
the Constant-Murley Score (CMS) at 1, 3, 6, and
12 months.
VAS
The VAS is a psychometric response scale used to meas-
ure subjective characteristics or attitudes that cannot be
directly assessed. When answering a VAS item, respon-
dents specify their level of agreement with a statement
by indicating a position along a continuous line between
two end-points [54]. In this study, a 0–10 cm VAS will
be used in the subjective evaluation of pain (no pain to
severe pain), fatigue (no fatigue to severe fatigue) and
sleep (good sleep to poor sleep) in the patients.
Circumference method
Arm circumference will be measured at 10 cm above
the wrist and 10 cm above the elbow using a leather
measuring tape. Lymphedema is defined as a difference
in arm circumference of more than 2 cm between the
treated and untreated side at either of the two mea-
sured locations on the limb [55]. The measurement of
arm circumference of all recruited patients will be con-
sistently performed at 5 pm at the baseline survey and
at each post-test.
CMS
The Chinese CMS has four subscales, including pain
(15 points maximum), activities of daily living (20
points maximum), range of motion (ROM, 40 points
maximum), and strength (25 points maximum). The
total score ranges from 0 to 100, with a higher score in-
dicating a higher quality of functioning [56]. A system-
atic review showed that the original CMS satisfied
psychometric properties of functional assessment [57].
Interventions
The intervention arm
Patients in the intervention arm will receive the MSNP
based on routine nursing care delivered by trained clin-
ical nurses immediately after recruitment. The MSNP
includes physical care, help with psychological adjust-
ment, and social support, aiming to improve the phys-
ical, psychological, and social functioning of the patients,
respectively. Detailed information on the MSNP content
and implementation are shown in Table 1.
Fig. 2 Flowchart of the trial. (FACT-Bv4.0: Functional Assessment of Cancer Therapy-Breast version 4.0; VAS: visual analogue scale; CMS: Constant-
Murley Score; MSNP: multimodal standard nursing program.)
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The control arm
Patients in the control arm will only receive routine nurs-
ing care, including vital signs observation, nursing specific
to surgery, drainage tube nursing, fundamental exercises
after surgery, and post-operative complications monitoring.
Masking
All recruited female patients with breast cancer, partici-
pating clinical staff, and trained data collectors of the 12
hospitals will be blinded to the allocation information. Pa-
tients in the control arm will not be offered any informa-
tion on the MSNP during the study period in case of bias.
The trial statistician will also be blinded to the treat-
ment code during development of the statistical analysis
plan and writing of the statistical programs, which will
be validated and completed using dummy randomization
codes. The actual allocation will only be provided to the
study team after locking of the database.
Table 1 Outline of the multimodal standard nursing program (MSNP)
Section Target Content Implementation Special attention
Physical care Physical function Systematic functional exercises
• Upper limb exercise
(two-sides)
Exercises of the finger, wrist,
forearm, elbow, upper arm,
shoulder, head & neck; 5–10




should limit the time and
strength of exercise.
Continue to the end of
follow-up.
• Aerobic exercise Walking up and down stairs,
3–6 times per day, 30 min
per session.
• Progressive muscle relaxation Sitting or lying, relaxing from
head to feet, 3–6 times per
day, 30 min per session.
Psychological adjustment Psychological function Psychological counseling Nurse-conducted one-to-one
communication on the
patient’s psychological problems;
twice per week, 30–60 min
per session in the hospital.
Need-oriented counseling is
delivered via outpatient review
or telephone after discharge
from the hospital.
Continue to the end of
follow-up.
Music listening Listening to patient’s preferred
light music via MP3 player;
twice per day (7 a.m.–9 a.m.
and 9 p.m.–11 p.m.), 30 min
per session.
Patients with sound allergy
or who dislike listening to
music should not be given
such intervention.
Continue to the end of
follow-up.
Interactive distraction Need-oriented communication
with caregivers or peers while
in a negative mood.
Continue to the end of
follow-up.
Social support Social family function Family support training Training caregivers on the
monitoring of the patient’s
diet, exercise, rest and illness,
as well as coping with the
negative influences of breast
cancer on families.
Once per week, 60 min per
session in the hospital.
Need-oriented training is
delivered via outpatient review
after discharge from
the hospital.
Continue to the end of
follow-up.
Peer group support Rehabilitation experiences
exchange between the patient
and peers, discussing successful
recovery in a chatty manner.
Once per week, 60 min per
session in hospital setting.
Need-oriented support is delivered
via outpatient review after discharge
from the hospital.
Continue to the end of
follow-up.
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Data management and analyses
SAS 9.4 and SPSS 22.0 will be employed to perform all
statistical analyses. All quantitative data will be collected
using paper questionnaires with unique ID numbers for
each recruited patient. Data will be stored at the re-
search team office at the end of each day. Daily checking
of data will be carried out by the research coordinator,
with queries identified and resolved promptly. A data-
base will be built using Epidata3.1; double entry and
checking will be performed by an assigned data entry
team. Discrepancies will be resolved by a third data man-
ager. Once in an electronic file, all data will be password
protected, with data managers controlling access to pass-
words and ensuring the database is backed up daily.
Findings of the trial will be reported according to the
CONSORT guidelines for cRCT. Primary analyses will
be based on an intention-to-treat (ITT) population and
secondary analyses on a per-protocol (PP) population.
The primary endpoint will be analyzed using a linear
mixed model with intervention, time, and interaction be-
tween intervention and time as fixed effects, baseline
measurement as covariate, and cluster and patient as
random effects. The intervention difference at each time,
together with its 95 % confidence interval will be derived
from the mixed model. Missing data will be treated as
missing at random in the above mixed model analysis
and no imputation will be made. To assess the sensitivity
of the result of this assumption, the last observation car-
ried forward (LOCF) strategy will be used to compute
missing HRQoL scores during follow-up. A covariate-
adjusted mixed model of the primary endpoint will be
tested by adding pre-specified covariates at baseline into
the linear mixed model. Subgroup analysis will be per-
formed on the pre-specified covariates.
Continuous secondary outcomes will be analyzed in a
similar way to the primary endpoint analysis. For the ana-
lysis of binary secondary outcomes, a generalized mixed
model will be employed with intervention, time, and the
interaction between intervention and time as fixed effects,
baseline measurement as covariate, and cluster and pa-
tient as random effects. The odds ratio (OR) between the
two arms at each time, together with its 95 % CI will be
derived from the generalized mixed model.
All analyses will be described in detail in the finalized
and signed statistical analysis plan before unmasking
the study.
Ethical approval
The trial protocol received ethical approval from the
Biomedical Ethics Committee of Xi’an Jiaotong University
Health Science Center. Written informed consent will be
obtained from each recruited patient before the interven-
tion and questionnaire survey.
Discussion
To improve HRQoL in female patients with breast can-
cer, novel intervention strategies that can improve phys-
ical, psychological, and social functions as well as sustain
those improvements over time are required. This trial
will examine the effectiveness of an MSNP in improving
HRQoL compared to routine nursing care. The efficacy
of the intervention on pain, fatigue, sleep, BCRL, and
upper limb function will also be tested. The MSNP has
several advantages over routine nursing care: (i) it is
constructed based on validated evidence and within the
theoretical framework of the HBM; (ii) taking into con-
sideration physical, psychological, and social health do-
mains, it outlines comprehensive nursing strategies for
HRQoL improvement mainly in clinical contexts; and
(iii) it may improve self-management of health in female
patients with breast cancer, because patients will receive
follow-up health instructions from nurses at home or in
community settings.
Even in the case of null results, this trial will produce
a large amount of illuminating data. Investigators will be
able to closely monitor HRQoL in both arms during the
12-month follow-up period. If the MSNP is effective, it
will provide an additional nursing care option for com-
prehensive health management of the population of fe-
male patients with breast cancer.
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